Moberg ICU Solutions (www.moberg.com) is a medical device manufacturing company that provides solutions for urgent, acute, and surgical care of neurological patients. Moberg ICU Solution's mission is to develop an integrated and patient-centric information environment to improve patient safety and optimize care. Technology produced by Moberg ICU Solutions provides the most advanced monitoring solutions in the field of neurocritical care. The Comp... View company details

Neuro Probe designs, manufactures, and sells a wide range of chemotaxis instruments, filters, and accessories. Our products include reusable instruments including Boyden chambers, and a line of disposable instruments, the ChemoTx®. Our product pipeline contains new cell activity assay instruments for high content screening (HCS) and high throughput screening (HTS). Our mission is to provide high quality instruments and innovative solutions for r... View company details

Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of dyslipidemia and nonalcoholic fatty liver disease (NAFLD/NASH). The company is developing gemcabene, a novel, once-daily, and oral therapy for dyslipidemia conditions where patients are unable to reach their lipid lowering goals, including patients already receiving maximally tolerated statin therapy. It... View company details

Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company offers INGREZZA (valbenazine), a vesicular monoamine transporter 2 inhibitor (VMAT2), which is used for the treatment of movement disorders; ORILISSA, a gonadotropin-releasing hormone (GnRH) antagonist for use in women's health. Its product candidates in clinical devel... View company details